- Posted August 7, 2013 by
Independent Pharmacy Cooperative Reaches Deal on Premature Ejaculation Product
The IPC is considered the largest purchasing organization for independent pharmacies, making this deal significant for men who suffer from premature ejaculation.
According to Medscape, premature ejaculation (PE) is the most common sexual disorder in men younger than 40, with “30-70% males in the United States affected to some degree at one time or another.”
Promescent is advertised as a topical spray that is applied on-demand rather than with a daily dose. AP also prides itself as having the only FDA-approved product for PE treatment.
Topical sprays and creams contain one or more anesthetic agents which desensitize the penis to sexual stimulation, enabling the man to delay ejaculation . They are applied at some period before intercourse, depending on the product.
Besides topical cream, antidepressants are often prescribed because of the side effect, which delays orgasm. This is not the approved method of treatment but has been known to have effect.
Other treatments include certain sexual therapies, which would be recommended by your doctor, as well as possible behavioral therapy if the problem were deemed mental rather than physical. Stress and anxiety have also been linked to performance issues.
Unfortunately, there is no known cure, and there still is not a known reason as to why PE occurs. The medical community has improved its research and has gained much more knowledge about the dysfunction, however, which has improved overall treatment and response for men.
PE is a topic that has only recently come into mainstream discussion. Due to its sensitive nature, few men seem to want to publicly talk about it, especially to their doctors. UrologyHealth.com (link below) stresses the importance of discussing PE with both your partner and your doctor.
Consult your doctor before trying any new products or treatments.